Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
19/10/201901h57Dow Jones NewsMore Money Demanded in Opioid Settlement TalksNYSE:TEVATeva Pharmaceutical Industries Ltd
18/10/201909h02Dow Jones NewsBellwether Opioid Deal Talks Ramp Up -- WSJNYSE:TEVATeva Pharmaceutical Industries Ltd
18/10/201900h15Dow Jones NewsTalks to Settle Opioid Lawsuits IntensifyNYSE:TEVATeva Pharmaceutical Industries Ltd
07/10/201923h00Business WireTeva to Host Conference Call to Discuss Third Quarter 2019 Financial Results at 8 a.m. ET on November 7, 2019NYSE:TEVATeva Pharmaceutical Industries Ltd
02/10/201914h30Business WireTeva to Present New Data on AUSTEDO® (deutetrabenazine) Tablets at Psych Congress 2019NYSE:TEVATeva Pharmaceutical Industries Ltd
02/10/201914h00Business WireTeva Announces Leadership Change in its Global Operations GroupNYSE:TEVATeva Pharmaceutical Industries Ltd
30/09/201923h41Dow Jones NewsDrugmakers Look to Use Purdue Pharma's Bankruptcy to Settle Opioid SuitsNYSE:TEVATeva Pharmaceutical Industries Ltd
13/09/201919h52Dow Jones NewsCorrection to Opioid Reckoning Hits Money ManagersNYSE:TEVATeva Pharmaceutical Industries Ltd
13/09/201914h29Dow Jones NewsOpioid Reckoning Hits Money ManagersNYSE:TEVATeva Pharmaceutical Industries Ltd
13/09/201911h00PR Newswire (US)INTERCURE: CANNDOC signs strategic distribution agreement with S.L.E. of TEVA PharmaceuticalsNYSE:TEVATeva Pharmaceutical Industries Ltd
05/09/201904h05Business WireTeva präsentiert neue Analysen zur Wirksamkeit und Sicherheit von Fremanezumab bei erwachsenen Patienten mit schwer behandel...NYSE:TEVATeva Pharmaceutical Industries Ltd
04/09/201923h18Business WireTeva présentera de nouvelles analyses sur l'efficacité et l'innocuité du fremanezumab chez les patients adultes atteints d...NYSE:TEVATeva Pharmaceutical Industries Ltd
04/09/201922h14Business WireTeva to Present New Analyses of Fremanezumab Efficacy & Safety in Adult Patients with Difficult-to-Treat Migraine at 19th Con...NYSE:TEVATeva Pharmaceutical Industries Ltd
03/09/201922h05Business WireTeva Announces United States Department of Commerce Appointment of Brendan O’Grady to Investment Advisory CouncilNYSE:TEVATeva Pharmaceutical Industries Ltd
27/08/201922h14Dow Jones NewsShares of Mallinckrodt, Endo, Teva, Drugmakers With Opioid Business, FallNYSE:TEVATeva Pharmaceutical Industries Ltd
21/08/201914h00Business WireFremanezumab Data in The Lancet Demonstrate Clinically Meaningful Reduction in Monthly Migraine Days Versus Placebo for Patie...NYSE:TEVATeva Pharmaceutical Industries Ltd
20/08/201914h00Business WireTeva Announces Availability of a Generic Equivalent of EpiPen Jr® (epinephrine injection, USP) Auto-Injector, 0.15 mg in the...NYSE:TEVATeva Pharmaceutical Industries Ltd
07/08/201921h00Dow Jones NewsTeva Seeks New CFO As It Faces High Debt Levels, Opioid Litigation -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
07/08/201913h05Business WireTeva Announces CFO Leadership TransitionNYSE:TEVATeva Pharmaceutical Industries Ltd
07/08/201913h00Business WireTeva Reports Second Quarter 2019 Financial ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
22/07/201917h36Dow Jones NewsFDA Approves Multiple Applications for Generic Version of LyricaNYSE:TEVATeva Pharmaceutical Industries Ltd
17/07/201923h15Dow Jones NewsMedical Distributors Stocks Fall After Opioid Data ReportsNYSE:TEVATeva Pharmaceutical Industries Ltd
15/07/201915h33Dow Jones NewsTeva Pharmaceutical Says FDA Approves AirDuo Digihaler Inhalation PowderNYSE:TEVATeva Pharmaceutical Industries Ltd
15/07/201914h30Business WireTeva Announces FDA Approval of AirDuo® Digihaler™ (fluticasone propionate 113 mcg and salmeterol 14 mcg) Inhalation PowderNYSE:TEVATeva Pharmaceutical Industries Ltd
11/07/201914h07Business WireTeva Completes Facilities Purchase in Pennsylvania for North America Research & Development CampusNYSE:TEVATeva Pharmaceutical Industries Ltd
10/07/201915h17Business WireTeva to Present New Data on AJOVY® (fremanezumab-vfrm) Injection at the American Headache Society’s 61st Annual Scientific...NYSE:TEVATeva Pharmaceutical Industries Ltd
03/07/201923h00Business WireTeva to Host Conference Call to Discuss Second Quarter 2019 Financial Results at 8 a.m. ET on August 7, 2019NYSE:TEVATeva Pharmaceutical Industries Ltd
02/07/201908h30Business WireTeva Presents Positive Results Showing Improvement in Disability & Quality of Life from the Phase IIIb FOCUS study of Fremane...NYSE:TEVATeva Pharmaceutical Industries Ltd
01/07/201914h30Business WireTeva Announces Launch of 1% Sodium Hyaluronate in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
19/06/201919h00Business WireTeva Announces Launch of a Generic Version of Tracleer® (bosentan) Tablets in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA